top of page


Senthil Selvaraj
Sep 19, 20231 min read
Advantages of using WHO Drug ATC Classification for Disproportionality Analysis
WHO Drug Anatomical Therapeutic Chemical (ATC) Classification organizes drugs into 14 major groups. These groups are further...
9 views

Senthil Selvaraj
Jul 6, 20231 min read
Biktarvy - Weight increased potential signal
FDA 2023 Q1 potential signals include Biktarvy (bictegravir, emtricitabine, and tenofovir alafenamide) - Weight increased as a potential...
17 views0 comments

Senthil Selvaraj
May 9, 20231 min read
PD-1/PDL-1 inhibitors - Keratoacanthoma potential signal
PD-1/PDL-1 inhibitors potential signal
4 views0 comments

Senthil Selvaraj
May 9, 20231 min read
Ocrevus (ocrelizumab) - Progressive multifocal leukoencephalopathy potential signal
As of Dec 2022, 27 Progressive multifocal leukoencephalopathy reports were in the FAERS database for Ocrelizumab. The PRRs are below 2...
6 views0 comments

Senthil Selvaraj
May 4, 20231 min read
HMG-CoA reductase inhibitors - DRESS potential signal
Posted potential safety issue As of Dec 2022, there were a few HMG-CoA reductase inhibitors with DRESS adverse event PRR > 2. Some of the...
12 views0 comments

Senthil Selvaraj
May 4, 20231 min read
Addyi (flibanserin) - Accidental exposure to product by child potential signal
As of Dec 2022, 20 Accidental exposure to product by child reports were in the FAERS database for Flibanserin. The PRRs are above 2 for...
5 views0 comments

Senthil Selvaraj
May 3, 20232 min read
Disproportionality Analysis
An easy way to analyze your drug for potential signals
22 views0 comments
bottom of page